Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
Identifieur interne : 000220 ( PubMed/Curation ); précédent : 000219; suivant : 000221Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
Auteurs : Valentina Spezzani [Italie] ; Alessio Piunno [Italie] ; Hans-Ulrich Iselin [Suisse]Source :
- Swiss medical weekly [ 1424-3997 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antibactériens (usage thérapeutique), Antiviraux (usage thérapeutique), Cobicistat (usage thérapeutique), Conjoints, Darunavir (usage thérapeutique), Dyspnée (étiologie), Femelle, Fièvre (étiologie), Humains, Hydroxychloroquine (usage thérapeutique), Immunocompétence, Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Mâle, Pandémies, Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (virologie), Récidive tumorale locale (traitement médicamenteux), Résultat thérapeutique, Service hospitalier d'urgences, Soins de réanimation, Sujet immunodéprimé, Tumeurs du sein ().
- MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale, Récidive tumorale locale.
- usage thérapeutique : Antibactériens, Antiviraux, Cobicistat, Darunavir, Hydroxychloroquine.
- virologie : Infections à coronavirus, Pneumopathie virale.
- étiologie : Dyspnée, Fièvre.
- Adulte d'âge moyen, Conjoints, Femelle, Humains, Immunocompétence, Mâle, Pandémies, Résultat thérapeutique, Service hospitalier d'urgences, Soins de réanimation, Sujet immunodéprimé, Tumeurs du sein.
English descriptors
- KwdEn :
- Anti-Bacterial Agents (therapeutic use), Antiviral Agents (therapeutic use), Betacoronavirus, Breast Neoplasms (complications), Cobicistat (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (virology), Critical Care, Darunavir (therapeutic use), Dyspnea (etiology), Emergency Service, Hospital, Female, Fever (etiology), Humans, Hydroxychloroquine (therapeutic use), Immunocompetence, Immunocompromised Host, Male, Middle Aged, Neoplasm Recurrence, Local (drug therapy), Pandemics, Pneumonia, Viral (drug therapy), Pneumonia, Viral (virology), Spouses, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Antiviral Agents, Cobicistat, Darunavir, Hydroxychloroquine.
- complications : Breast Neoplasms.
- drug therapy : Coronavirus Infections, Neoplasm Recurrence, Local, Pneumonia, Viral.
- etiology : Dyspnea, Fever.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, Critical Care, Emergency Service, Hospital, Female, Humans, Immunocompetence, Immunocompromised Host, Male, Middle Aged, Pandemics, Spouses, Treatment Outcome.
Abstract
Respiratory failure in COVID-19 is a common feature in fatal cases and has been considered as a failure of the immune system to control the virus. Here we report the case of COVID-19 affecting an immunocompromised women and her presumably immunocompetent spouse. A married couple (age 60 years) was simultaneously admitted to the emergency department on 10 March 2020 because of dyspnoea and fever, consistent with COVID-19. The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension. Both patients were treated with darunavir/cobicistat and hydroxychloroquine. The clinical course of the immunocompromised partner was benign, without need of intensive care. She was able to leave the hospital on day 6 after admission. In contrast, her husband needed intensive care and his recovery was slow, although eventually successful too. These findings suggest that the course of COVID-19 is not necessarily ominous in the presence of a compromised immune response and tend to reinforce the emerging therapeutic concepts of a controlled mitigation of the immune cascade following SARS CoV-2 infection.
DOI: 10.4414/smw.2020.20246
PubMed: 32277836
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000220
Links to Exploration step
pubmed:32277836Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.</title><author><name sortKey="Spezzani, Valentina" sort="Spezzani, Valentina" uniqKey="Spezzani V" first="Valentina" last="Spezzani">Valentina Spezzani</name><affiliation wicri:level="1"><nlm:affiliation>Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena</wicri:regionArea></affiliation></author><author><name sortKey="Piunno, Alessio" sort="Piunno, Alessio" uniqKey="Piunno A" first="Alessio" last="Piunno">Alessio Piunno</name><affiliation wicri:level="1"><nlm:affiliation>Radiology, Ospedale di Sassuolo (Prov. Modena), Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Radiology, Ospedale di Sassuolo (Prov. Modena)</wicri:regionArea></affiliation></author><author><name sortKey="Iselin, Hans Ulrich" sort="Iselin, Hans Ulrich" uniqKey="Iselin H" first="Hans-Ulrich" last="Iselin">Hans-Ulrich Iselin</name><affiliation wicri:level="1"><nlm:affiliation>Consultant for Interprofessional Communication, Riehen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Consultant for Interprofessional Communication, Riehen</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32277836</idno><idno type="pmid">32277836</idno><idno type="doi">10.4414/smw.2020.20246</idno><idno type="wicri:Area/PubMed/Corpus">000220</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000220</idno><idno type="wicri:Area/PubMed/Curation">000220</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000220</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.</title><author><name sortKey="Spezzani, Valentina" sort="Spezzani, Valentina" uniqKey="Spezzani V" first="Valentina" last="Spezzani">Valentina Spezzani</name><affiliation wicri:level="1"><nlm:affiliation>Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena</wicri:regionArea></affiliation></author><author><name sortKey="Piunno, Alessio" sort="Piunno, Alessio" uniqKey="Piunno A" first="Alessio" last="Piunno">Alessio Piunno</name><affiliation wicri:level="1"><nlm:affiliation>Radiology, Ospedale di Sassuolo (Prov. Modena), Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Radiology, Ospedale di Sassuolo (Prov. Modena)</wicri:regionArea></affiliation></author><author><name sortKey="Iselin, Hans Ulrich" sort="Iselin, Hans Ulrich" uniqKey="Iselin H" first="Hans-Ulrich" last="Iselin">Hans-Ulrich Iselin</name><affiliation wicri:level="1"><nlm:affiliation>Consultant for Interprofessional Communication, Riehen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Consultant for Interprofessional Communication, Riehen</wicri:regionArea></affiliation></author></analytic><series><title level="j">Swiss medical weekly</title><idno type="eISSN">1424-3997</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (therapeutic use)</term><term>Antiviral Agents (therapeutic use)</term><term>Betacoronavirus</term><term>Breast Neoplasms (complications)</term><term>Cobicistat (therapeutic use)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (virology)</term><term>Critical Care</term><term>Darunavir (therapeutic use)</term><term>Dyspnea (etiology)</term><term>Emergency Service, Hospital</term><term>Female</term><term>Fever (etiology)</term><term>Humans</term><term>Hydroxychloroquine (therapeutic use)</term><term>Immunocompetence</term><term>Immunocompromised Host</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local (drug therapy)</term><term>Pandemics</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (virology)</term><term>Spouses</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antibactériens (usage thérapeutique)</term><term>Antiviraux (usage thérapeutique)</term><term>Cobicistat (usage thérapeutique)</term><term>Conjoints</term><term>Darunavir (usage thérapeutique)</term><term>Dyspnée (étiologie)</term><term>Femelle</term><term>Fièvre (étiologie)</term><term>Humains</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Immunocompétence</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (virologie)</term><term>Mâle</term><term>Pandémies</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Pneumopathie virale (virologie)</term><term>Récidive tumorale locale (traitement médicamenteux)</term><term>Résultat thérapeutique</term><term>Service hospitalier d'urgences</term><term>Soins de réanimation</term><term>Sujet immunodéprimé</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Antiviral Agents</term><term>Cobicistat</term><term>Darunavir</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Neoplasm Recurrence, Local</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyspnea</term><term>Fever</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Récidive tumorale locale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Antiviraux</term><term>Cobicistat</term><term>Darunavir</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Dyspnée</term><term>Fièvre</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Critical Care</term><term>Emergency Service, Hospital</term><term>Female</term><term>Humans</term><term>Immunocompetence</term><term>Immunocompromised Host</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Spouses</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Conjoints</term><term>Femelle</term><term>Humains</term><term>Immunocompétence</term><term>Mâle</term><term>Pandémies</term><term>Résultat thérapeutique</term><term>Service hospitalier d'urgences</term><term>Soins de réanimation</term><term>Sujet immunodéprimé</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Respiratory failure in COVID-19 is a common feature in fatal cases and has been considered as a failure of the immune system to control the virus. Here we report the case of COVID-19 affecting an immunocompromised women and her presumably immunocompetent spouse. A married couple (age 60 years) was simultaneously admitted to the emergency department on 10 March 2020 because of dyspnoea and fever, consistent with COVID-19. The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension. Both patients were treated with darunavir/cobicistat and hydroxychloroquine. The clinical course of the immunocompromised partner was benign, without need of intensive care. She was able to leave the hospital on day 6 after admission. In contrast, her husband needed intensive care and his recovery was slow, although eventually successful too. These findings suggest that the course of COVID-19 is not necessarily ominous in the presence of a compromised immune response and tend to reinforce the emerging therapeutic concepts of a controlled mitigation of the immune cascade following SARS CoV-2 infection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32277836</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1424-3997</ISSN><JournalIssue CitedMedium="Internet"><Volume>150</Volume><PubDate><Year>2020</Year><Month>04</Month><Day>06</Day></PubDate></JournalIssue><Title>Swiss medical weekly</Title><ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation></Journal><ArticleTitle>Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.</ArticleTitle><Pagination><MedlinePgn>w20246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2020.20246</ELocationID><ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2020;150:w20246</ELocationID><Abstract><AbstractText>Respiratory failure in COVID-19 is a common feature in fatal cases and has been considered as a failure of the immune system to control the virus. Here we report the case of COVID-19 affecting an immunocompromised women and her presumably immunocompetent spouse. A married couple (age 60 years) was simultaneously admitted to the emergency department on 10 March 2020 because of dyspnoea and fever, consistent with COVID-19. The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension. Both patients were treated with darunavir/cobicistat and hydroxychloroquine. The clinical course of the immunocompromised partner was benign, without need of intensive care. She was able to leave the hospital on day 6 after admission. In contrast, her husband needed intensive care and his recovery was slow, although eventually successful too. These findings suggest that the course of COVID-19 is not necessarily ominous in the presence of a compromised immune response and tend to reinforce the emerging therapeutic concepts of a controlled mitigation of the immune cascade following SARS CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spezzani</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piunno</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiology, Ospedale di Sassuolo (Prov. Modena), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iselin</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Consultant for Interprofessional Communication, Riehen, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Swiss Med Wkly</MedlineTA><NlmUniqueID>100970884</NlmUniqueID><ISSNLinking>0036-7672</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>LW2E03M5PG</RegistryNumber><NameOfSubstance UI="D000069547">Cobicistat</NameOfSubstance></Chemical><Chemical><RegistryNumber>YO603Y8113</RegistryNumber><NameOfSubstance UI="D000069454">Darunavir</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069547" MajorTopicYN="N">Cobicistat</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069454" MajorTopicYN="N">Darunavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007121" MajorTopicYN="N">Immunocompetence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32277836</ArticleId><ArticleId IdType="doi">10.4414/smw.2020.20246</ArticleId><ArticleId IdType="pii">Swiss Med Wkly. 2020;150:w20246</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000220 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000220 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32277836
|texte= Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32277836" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |